Benefit of Anakinra in Treating Pediatric Secondary Hemophagocytic Lymphohistiocytosis

Eloseily, Esraa M., Weiser, Peter, Crayne, Courtney B., Haines, Hilary, Mannion, Melissa L., Stoll, Matthew L., Beukelman, Timothy, Atkinson, T. Prescott +1 more·2020·Arthritis & Rheumatology
DOI 10.1002/art.41103

Cited by (281)

Items 201–281 of 281

  1. Whole-process management of complications during CAR-T therapy
    Yingying Li, Heng Mei · 2022 · Hematology and Oncology Discovery
  2. Use of Anakinra in a Case of Severe Dengue with Refractory Secondary Hemophagocytic Lymphohistiocytosis
    Kaustabh Chaudhuri, Anumita Biswanath Chatterjee, Priyankar Pal · 2024 · Indian Pediatrics Case Reports
  3. Clinical characteristics of hemophagocytic lymphohistiocytosis
    Cancan Lu, Jimin Shi, Yamin Tan, Huixian Hu · 2024 · Technology and Health Care
  4. CD8+ T Cell Biology in Cytokine Storm Syndromes
    Takuya Sekine, Donatella Galgano, Giovanna Perinetti Casoni, Marie Meeths, Randy Quentin Cron, Yenan T. Bryceson · 2024 · Advances in experimental medicine and biology
  5. Opciones terapéuticas en el manejo de la COVID-19 grave: una perspectiva de Reumatología
    Claudia Mendoza Pinto, Mario García‐Carrasco, Pamela Munguía‐Realpozo, Socorro Méndez‐Martínez · 2020 · Reumatología Clínica
  6. Cytokine storm is the cryptic killer behind coronavirus disease-2019 infections, review of the current evidence to identify therapeutic options
    Diaa Alrahmany, Islam M. Ghazi · 2020 · Reviews in Medical Microbiology
  7. Higher Frequency and Poor Prognosis with COVID-19 Associated Cytokine Storm among Cancer Patients: Between Two Fires
    Murat Bektaş, Nevzat Koca, B. İnce · 2022 · Journal of Cancer Immunology
  8. Traffic jam within lymphocytes: A clinician’s perspective
    Smitha Hosahalli Vasanna, Jignesh D Dalal · 2023 · Frontiers in Immunology
  9. Does your unwell patient have haemophagocytic lymphohistiocytosis?
    Amelia M. Holloway, Saad Ahmed, Jessica J. Manson · 2024 · British Journal of Hospital Medicine
  10. Myeloma‐associated hemophagocytic lymphohistiocytosis – A comprehensive case study and a novel chemotherapy‐free approach with anakinra
    Maged Al‐Ammari, Danny Chung Hsu, Adam J Bryant · 2024 · eJHaem
  11. Increased ferritin, serum lactate dehydrogenase, and aspartate aminotransferase levels predict macrophage activation syndrome complicating systemic lupus erythematosus: a retrospective study
    Yingying Liu, Yuting Pan, Jing Jin, Panpan Wang, Tonghao Zhang, Zhidan Fan, Haiguo Yu · 2024 · Frontiers in Pediatrics
  12. Cytokines in hematopoietic cell transplantation and related cellular therapies
    Abdul Hamid Bazarbachi, Markus Y. Mapara · 2024 · Best Practice & Research Clinical Haematology
  13. Etiologies and long-term outcome of pediatric hemophagocytic lymphohistiocytosis and macrophage activation syndrome in Taiwan: a single-center retrospective study
    Ching-Yu Wang, Jyh‐Hong Lee, Ni‐Chung Lee, Ya‐Chiao Hu, Hsiu‐Hao Chang, Li‐Chieh Wang, Yu‐Tsan Lin, Yao‐Hsu Yang, Bor‐Luen Chiang, Hsin‐Hui Yu · 2025 · Frontiers in Immunology
  14. Development of an early mortality risk prediction model for pediatric patients with secondary hemophagocytic lymphohistiocytosis
    Nandu Luo, Guangli Yang, Pingping Zhang, Baoli Li, Yan Chen, Zuochen Du, Pei Yu Huang · 2025 · The Italian Journal of Pediatrics/Italian journal of pediatrics
  15. Chimeric antigen receptor T-cell therapies related to immune effector cell-associated hemophagocytic lymphohistiocytosis-like syndrome: Diagnosis, high-risk factors, and management
    Yuan Clare Zhang, Jilong Yang, Huiqi Xin, Kexin Ai, Mengsu Yang, Yuhua Li, Yanjie He · 2026 · Chinese Medical Journal
  16. Linfohistiocitosis Hemofagocítica (HLH) en pediatría; nuevas opciones terapéuticas.
    Valeria Elsy Chamba Cruz, Aliz Borja · 2022 · The Ecuador Journal of Medicine
  17. A MASsive attack: a pediatric case of macrophage activation syndrome complicated by DIC as an onset of systemic juvenile idiopathic arthritis successfully treated with anakinra and review of the literature
    Anna Maeser, Małgorzata Biernacka-Zielińska, Elżbieta Barbara Smolewska · 2024 · Rheumatology International
  18. COVID-19-Related Multi-systemic Inflammatory Syndrome in Children (MIS-C)
    Lauren A. Henderson · 2024 · Advances in experimental medicine and biology
  19. Cytokine Storm Syndrome Associated with Systemic Juvenile Idiopathic Arthritis
    Sebastiaan J. Vastert, Susan Canny, Scott Canna, Rayfel Schneider, Elizabeth Mellins · 2024 · Advances in experimental medicine and biology
  20. Unmet needs and research gaps in Still’s disease across ages: proceedings from a pediatric and adult joint expert panel
    Claudia Bracaglia, Francesca Minoia, Sebastiaan J. Vastert, Christoph Kessel, Lorenzo Dagna, Angelo Ravelli, Fabrizio De Benedetti · 2025 · Pediatric Rheumatology
  21. Anakinra for patients with COVID-19: an updated systematic review and meta-analysis
    Giulio Cavalli, Paolo Navalesi, Giovanni Landoni, Andrey G. Yavorovskiy, Valery V. Likhvantsev, Alberto Zangrillo, Lorenzo Dagna, Giacomo Monti, Laura Pasin · 2023 · Signa Vitae
  22. Risk factors of early death in pediatric hemophagocytic lymphohistocytosis: Retrospective cohort study
    Lijun Zhang, Lei Dai, Deyuan Li · 2022 · Frontiers in Pediatrics
  23. A rare onset in tumour necrosis factor receptor–associated periodic syndrome: recurrent macrophage activation syndrome triggered by COVID-19 infection
    Şengül Çağlayan, Kadir Ulu, Mustafa Çakan, Betül Sözeri · 2022 · Lara D. Veeken
  24. Response to: ‘Successful treatment of plasma exchange for refractory systemic juvenile idiopathic arthritis complicated with macrophage activation syndrome and severe lung disease’ by Sato et al
    Vivian E Saper, Guangbo Chen, Robert Paul Guillerman, Purvesh Khatri, Randy Quentin Cron, Elizabeth Mellins · 2020 · Annals of the Rheumatic Diseases
  25. Severe Adenovirus Pneumonia Associated With Hemophagocytic Lymphohistiocytosis With Coronary Involvement
    Pooja Chowdhury, Sayantika Saha, Säumen Meur · 2023 · Indian Pediatrics
  26. Effective Treatment of Macrophage Activation Syndrome Linked to Systemic Lupus Erythematosus Using Interleukin-1 Inhibitor
    Nur Barlas, Ikwinder Preet Kaur, Cristine Kuzhuppilly Arcilla, Gurjit Singh Kaeley, Myint Thway · 2025 · Cureus
  27. Kawasaki Disease Complicated with Macrophage Activation Syndrome: Update on Diagnosis and Treatment
    Kyoungsoon Cho, Soo Young Lee · 2025 · Kawasaki Disease
  28. Hemophagocytic Lymphohistiocytosis Gene Variants in Severe COVID-19 Cytokine Storm Syndrome
    Abhishek Kamath, Mingce Zhang, Devin Absher, Lesley E. Jackson, Walter Winn Chatham, Randy Quentin Cron · 2025 · Viruses
  29. Endotoxin retention in adipose tissue leading to persistent hypotension in catecholamine-dependent acute obstructive suppurative cholangitis
    Kun Li, Sibo Zhu, Chun Jing Ye, Yue Ding, Jiangxi Liu, Ying Wang, Zhiyong Wang, Wenfeng Li, DongHua Yang, X. Wang et al. · 2025 · Journal of Translational Internal Medicine
  30. Targeting the cytokine storm: new therapies in the treatment of pediatric hemophagocytic lymphohistiocytosis
    Hilary Cahill, Robert Francis Wynn, Srividhya Senthil · 2026 · Expert Review of Clinical Immunology
  31. Effective Multi-agent Therapy With Anakinra, Corticosteroids and Mycophenolate in Immunotherapy-Associated Haemophagocytic Lymphohistiocytosis (HLH)
    Anirban Deb Tanmoy, Fan Jiong Eaw, Charlotte Mykura, Dhanush Sheeba Pradeep, Samantha Gold · 2026 · Cureus
  32. Management of Other Toxicities
    Hermann Einsele, Ibrahim Yakoub‐Agha · 2022 · Springer eBooks
  33. Adult-onset Still’s Disease after COVID 19 Infection: Case Report
    Abdulameer M. Abu Nailah, Ahila A. M. Abu-Nayla, Umniyah A. M. Abu-Nayla · 2022
  34. Miscellaneous Complications of Chimeric Antigen Receptor T-Cell Therapy
    Fateeha Furqan, Paolo Strati · 2023 · Elsevier eBooks
  35. Hemophagocytic Lymphohistiocytosis Triggered by Acute Interstitial Pneumonitis in a Young Woman With Rheumatoid Arthritis
    Moemen Hasaballah, Mohamed Elsayed, Omar Shafey, Mohamed Abdulmajeed · 2025 · Cureus
  36. A Scopic Review on the Diagnostic Dilemmas and Newer Treatment Modalities in Hemophagocytic Lymphohistiocytosis
    Vinod Kumar Paul, Vyas Kumar Rathaur, Amanta Lucy Ittoop, Rajkumar Sananganba, Nowneet Kumar Bhat, Monika Pathania · 2020 · Journal of Pediatrics Perinatology and Child Health
  37. Treatment Failure with IVIG in a Case of Multisystem Inflammatory Syndrome in Children Managed by Tocilizumab
    Fahmida Zabeen, Mahafuj Hassan, Badrun Nessa, Sadia Khan, Jannatul Ferdouse · 2021 · Dhaka Shishu (Children) Hospital Journal
  38. Current strategies and future perspectives in COVID-19 therapy
    S.R. Aravind, Krupa Ann Mathew, Bernadette K. Madathil, S. Mini, Annie P John · 2022 · Elsevier eBooks
  39. Anakinra in COVID‐19—How to Interpret Elevations of Serum Liver Enzymes: Comment on the Article by Navarro‐Millán et al
    Giulio Cavalli, Lorenzo Dagna · 2020 · Arthritis & Rheumatology
  40. Comment on: The use of anakinra in the treatment of secondary hemophagocytic lymphohistiocytosis
    Paige Vicenzi, Zahra Jiwani, Ricardo Guirola, Tyler Hamby, Anish Ray · 2020 · Pediatric Blood & Cancer
  41. Dr. Degar et al reply
    Barbara A. Degar, Olha Halyabar, Melissa M. Hazen, Lauren A. Henderson · 2022 · The Journal of Rheumatology
  42. Adult-onset macrophage activation syndrome treated by interleukin-1 inhibition
    Francesca Della Casa, Angelica Petraroli, Ilaria Mormile, Gianluca Lagnese, Antonio di Salvatore, Francesca Wanda Rossi, Amato de Paulis · 2022 · Rheumatology Advances in Practice
  43. Cutaneous Histiocytoses
    Thai Hoa Tran, Elena Pope, Sheila S Weitzman · 2024
  44. A Recent Update on Histiocytic Disorder in Children: Focus on Diagnosis and Treatment
    Hoi Soo Yoon · 2020 · Imsang soa hyeoraek jong-yang/Imsang soa hyeol'aeg jong'yang/Clinical pediatric hematology-oncology
  45. Macrophage Activation Syndrome in Childhood Inflammatory Disorders: Diagnosis, Genetics, Pathophysiology, and Treatment
    Francesco Baldo, Gisella B. Beretta, Jessica Tibaldi, Roberta Caorsi, Francesca Minoia · 2020 · Current Treatment Options in Rheumatology
  46. Role of Immunomodulators in Secondary Hemophagocytic Lymphohistiocytosis
    Paige Vicenzi, Zahra Jiwani, Ricardo Guirola, Tyler Hamby, Anish Ray · 2020
  47. Linfohistiocitosis hemofagocítica secundaria/síndrome de liberación de citoquinas por SARS-CoV-2: una revisión concisa
    Mario Andrés Hernández-Somerson, Omar Bernal-Ramirez, Juan Camilo Jiménez-Palomino, Samuel Rodriguez-Urueña, Fernando Montoya-Agudelo · 2021 · Medicina Crítica
  48. VINCULACIÓN PRODUCTIVA, UN CASO DE ÉXITO
    Jesús Roberto López Santillán, Ricardo Ramón Torres Knight, Norma Leticia Méndez Mariscal, Javier González Cantú · 2013
  49. Anakinra Therapy for Hemophagocytic Lymphohistiocytosis
    Sarah Ndegwa, Alison Adams · 2022 · Canadian Journal of Health Technologies
  50. The Current Role for Biologic Medications in the Treatment of Pediatric COVID-19 and MIS-C
    Nicholas T. Woolf · 2022 · Pediatric Annals
  51. COVID-19 IN ADOLESCENT PATIENTS IN THE BRAZILIAN POPULATION WITH SICKLE CELL ANEMIA
    Felipe Zampieri Vieira Batista, Igor Domingos de Souza, Francisco José Mendes dos Reis Ramos, Hugo Vieira Ramos, Liliane Moretti Carneiro, Maria Lúcia Ivo, Alexandra Maria Almeida Carvalho, Priscila Gonçalves Soares dos Santos, Valdir Aragão do Nascimento · 2022 · International Journal for Innovation Education and Research
  52. Risk factors of in-hospital death in pediatric patients with hemophagocytic lymphohistiocytosis: A case-control study
    Lijun Zhang, Lei Dai, Deyuan Li · 2022 · Research Square
  53. Risk factors of in-hospital death in pediatric patients with hemophagocytic lymphohistiocytosis: A case-control study
    Lijun Zhang, Lei Dai, Deyuan Li · 2022 · Research Square
  54. The importance of a sepsis layered early warning system for critical patients.
    Hui Lian, Hongmin Zhang, Xin Ding, Xiaoting Wang · 2022 · PubMed Central
  55. Fever and the Inflammatory Response
    Jeanette Taveras, Octavio Ramilo, Asunción Mejías · 2022 · Elsevier eBooks
  56. Anakinra at the heart of the matter in MIS-C
    Daniel D. Reiff, Randy Quentin Cron · 2023 · Lara D. Veeken
  57. COVID-19 Hastalarında Düşük Ve Yüksek Doz Anakinra Kullanımının Mortalite Üzerine Etkisinin Karşılaştırılması Comparison of the Effects of Low-Dose and High-Dose Anakinra Treatment on Mortality in COVID-19 Patients
    Döndü Genç Moralar, Ülkü Aygen Türkmen, Osman Çelik, Serpil Şehirlioğlu, Zuhal Çavuş, Veysel Dinç · 2015 · AYDIN SAĞLIK DERGİSİ
  58. Secondary Hemophagocytic Lymphohistiocytosis with Severe Dengue: A Rare but Dreadful Complication
    Ashwani Kumar Sood, Saguna Pandit, Nidhi Chadha, Naresh I Jindal · 2023 · Pediatric Infectious Disease
  59. All available clinical data on anakinra in COVID-19: an updated comprehensive review
    Marzieh Shahrabi, Elnaz Khani, Fariba Pourkarim, Hoda Afsharirad, Mohammad Solduzian · 2024
  60. Successful management of haemophagocytic lymphohistiocytosis in an adolescent with newly diagnosed HIV/AIDS and histoplasmosis
    Yagiz Matthew Akiska, Wei Li Adeline Koay, Justin Unternaher, Natella Yurievna Rakhmanina · 2024 · BMJ Case Reports
  61. Macrophage activation syndrome secondary to systemic lupus erythematosus: lesson for the clinical nephrologist
    Sara Moscardino, Sikharulidze Anna, Beretta Lorenzo, Binda Valentina, Castellano Giuseppe · 2024 · Journal of Nephrology
  62. Salvage Therapy and Allogeneic Hematopoietic Cell Transplantation for the Severe Cytokine Storm Syndrome of Hemophagocytic Lymphohistiocytosis
    Rebecca A. Marsh · 2024 · Advances in experimental medicine and biology
  63. Antiviral properties of cannabidiol for the management of COVID-19
    Isaac Thom Shawa · 2024 · Elsevier eBooks
  64. Hemophagocytic Lymphohistiocytosis: A Case Report
    Shivansh Yadav, A Jayprakash, Rekha S Patil · 2025
  65. Genomic correlates of clinical CAR T cell activity
    Mark B. Leick, Baihe Sun, Filippo Birocchi, Kathleen Gallagher, Alexandra Bratt, Seunghun Han, Grace A. Martin, Harrison J. Silva, Rebecca C. Larson, Tyler M Chinsky et al. · 2026 · Science Immunology
  66. Identifying Hemophagocytic Lymphohistiocytosis using Electronic Health Records and Describing the Impact of Treatment on Outcomes (Preprint)
    Adam P. Yan, Süheyla Ocak, Martin Yi, Agata Wolochacz, Ida Mehrdadi, Ahmed Naqvi, Sumit Gupta, Lillian Sung · 2025
  67. Not Just Sjögren's: A Rare Life-Threatening Manifestation in a Pediatric Patient
    Elise Dahan, Abigail Cooley, Kendel Ridgeway, Basil M. Fathalla, Tarek Husien · 2025 · Cureus
  68. Additional file 1 of Macrophage activation syndrome in juvenile dermatomyositis: a case report and a comprehensive review of the literature
    Chang, Yong, Xueyan Shan, Ge, Yongpeng · 2023 · Figshare
  69. Rheumatologic emergencies in the emergency department: Recognition, red flags, and initial management
    Ashaq Hussain Parrey · 2026 · JEM International
  70. Identifying Hemophagocytic Lymphohistiocytosis and Describing Outcomes Using Computable Phenotypes: Retrospective Cohort Study
    Süheyla Ocak, Martin Yi, Agata Wolochacz, Ida Mehrdadi, Ahmed Naqvi, Sumit Gupta, Lillian Sung, Adam P. Yan · 2026 · JMIR Cancer
  71. Secondary Haemophagocytic Lymphohistiocytosis Triggered by Adult-Onset Still's Disease in Mid-trimester Pregnancy Initially Presenting as an Upper Respiratory Tract Infection: A Case Report
    Mst Hiramoti, Nahin Fardin Ruthi · 2026 · Cureus
  72. Comparative Analysis of Familial Versus Infectious Neonatal Hemophagocytic Lymphohistiocytosis
    Jacob Ron Greenmyer, Megan L. Anderson, Charles S. Cameron, Lincoln A. Kranz, Wyatt S. Hahn, Whitney S. Thompson, Mira A. Kohorst, Asmaa Ferdjallah, Catherine Martin, Alexis K. Kuhn et al. · 2026 · Journal of Pediatric Hematology/Oncology
  73. Refractory Autoimmune Hemophagocytic Lymphohistiocytosis in Adults: Multi-therapy Failure and the Limits of Salvage Transplantation
    Bsher Almaalouli, Hannah Smith, Gabriel Kirsch, Vincent Courant, Gurjit Singh Kaeley · 2026 · Cureus
  74. Macrophage Activation Syndrome
    Alexei A. Grom, Grant S. Schulert · 2026 · Elsevier eBooks
  75. Therapeutics: Biologics and Targeted Small Molecules
    Ruud H J Verstegen, Nicolino Ruperto, Hermine I. Brunner · 2026 · Elsevier eBooks
  76. Breaking the storm: canakinumab as salvage therapy for refractory macrophage activation syndrome in pediatric systemic lupus erythematosus—a case report
    Tarun Selvarajan, Lavanya Kannekanti, Ashlyn Green, Alexandra Zamora Smith, Sarwat Umer · 2026 · Pediatric Rheumatology
  77. Secondary hemophagocytic lymphohistiocytosis in pediatric patients: a single-center experience
    Mayada Abu Shanap, Aseel Bzour, Iyad Yasin Sultan, Rawad Rihani · 2026 · Frontiers in Pediatrics
  78. Anakinra in Hemophagocytic Lymphohistiocytosis Associated With Cytomegalovirus Infection in a Child With Acute Lymphoblastic Leukemia: A Case Report From Chile
    Raúl Bustos, Roberto Campos J, Gajardo Carolina · 2026 · Pediatric Blood & Cancer
  79. Treatment strategies for relapsed/refractory hemophagocytic lymphohistiocytosis in pediatric patients
    Man Wang, Lihui Wang, Cuiping Zhu, Zongxuan Huang, Yanling Tao · 2026 · Therapeutic Advances in Hematology
  80. Hemophagocytic Lymphohistiocytosis As the Initial Presentation of Occult Diffuse Large B-cell Lymphoma: A Diagnostic Challenge
    Kavish Khatib, Shamnas Abdul-Aziz, Kashif Khatib · 2026 · Cureus
  81. Hyperinflammatory syndromes in primary mitochondrial disease: A three-center case series and focused review
    Dan Ross Brooks, Eliza M. Gordon‐Lipkin, İbrahim Elsharkawi, Shannon Kruk, Madeleine Hesselgesser, Christine Eng, Weimin Bi, Lisa T. Emrick, Kristen S. Fisher, Peter J. McGuire et al. · 2026 · Molecular Genetics and Metabolism